Ruxolitinib for refractory/relapsed hemophagocytic lymphohistiocytosis
Haematologica
.
2020 May;105(5):e210-e212.
doi: 10.3324/haematol.2019.222471.
Epub 2019 Sep 12.
Authors
Jingshi Wang
1
,
Yini Wang
1
,
Lin Wu
1
,
Xinkai Wang
1
,
Zhili Jin
1
,
Zhuo Gao
1
,
Zhao Wang
2
Affiliations
1
Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
2
Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China zhaowww263@yahoo.com.
PMID:
31515353
PMCID:
PMC7193462
DOI:
10.3324/haematol.2019.222471
No abstract available
Publication types
Letter
MeSH terms
Humans
Lymphohistiocytosis, Hemophagocytic* / drug therapy
Nitriles
Pyrazoles / therapeutic use
Pyrimidines
Substances
Nitriles
Pyrazoles
Pyrimidines
ruxolitinib